Statistical Analyses 155
Where appropriate, Student's t tests were calculated using GraphPad InStat software. 156
Significance was set at p<0.05 and denoted as *p<0.05, **p<0.005, and ***p<0.0005. All
Results

159
Transient inhibition of TCR-stimulated bystander CD8 T cell proliferation during acute viral 160 infections 161
In order to study the susceptibility of bystander CD8 T cells to transient immune 162 suppression in a physiological setting, we developed in vivo models to track and to specifically 163 activate bystander CD8 T cells. We tested HY (male antigen-specific) and P14 (LCMV-specific) 164 TCR transgenic CD8 T cells for this purpose and defined bystander as a transgenic CD8 T cell 165 population that did not divide (dilute CFSE), proliferate (increase in cell number), or regulate 166 activation markers during the viral infection. As shown in Figure 1 There was a slight reduction in the number of HY CD8 T cells recovered from the LCMV-184 infected female mice compared to the naïve female mice ( Fig. 2A) , and the HY CD8 T cells that 185 remained in either female host had a naïve phenotype (data not shown). However, the HY CD8 186 T cells became activated and proliferated in the naïve male mice, resulting in an increase in their 187 overall cell number, but this proliferation was inhibited in the LCMV-infected male mice ( found that HY and P14 CD8 T cell proliferation was still inhibited in virus-infected mice, 231
whether Fas-FasL, TNF, or both pathways were blocked ( Table I and blood) for both transgenic models, indicating that the reduced expansion of TCR-stimulated 244 bystander CD8 T cells may only minimally be due to enhanced cell death. We also found that 245 the reduced number of TCR-stimulated transgenic T cells in the spleen was not due to 246 sequestration or specific trafficking to peripheral tissues such as lymph nodes, bone marrow, 247 peritoneum, lung, liver, or in the circulating blood, as we could not recover them in those 248 compartments (data not shown). 249
Reduced proliferation of TCR-stimulated bystander CD8 T cells in vivo is associated with 251 delayed division 252
Because the reduced proliferation of TCR-stimulated bystander CD8 T cells could not be 253 exclusively explained by their death, we questioned whether a defect in division accounted for 254 their diminished expansion. Thus, CFSE-labeled P14 CD8 T cells were assessed for dilution of 255 CFSE at various time points between 0 and 5 days after GP 33-45 peptide inoculation. As shown in 256 
Reduced proliferation of TCR-stimulated bystander CD8 T cells is not due to a defect in antigen 278 presentation during acute viral infection 279
The delayed onset of TCR-stimulated bystander CD8 T cell division could have been due 280 to a T cell intrinsic defect or could have been a consequence of aberrant antigen presentation 281 during the acute viral infection. However, the frequency of total CD11c + DC in the spleen at day 282 5 of PV infection (1.7 ± 0.17%, n = 8) was not different than that found in naïve mice (1.5 ± 283 0.08%, n = 6). Nevertheless, since our experiments relied on host APC to present the endogenous 284 . In the present study we noted that the peak inhibition of bystander T 333 cell proliferation occurred at day 3 after viral infection (Fig. 2C) ( Fig. 6A and B) , but there were no significant differences in the percent or total numbers of those 381 sensitized with poly(I:C) vs. those that were not treated (Fig. 6B, p > 0.9 ). This pattern of no 382 inhibition of the IFN-αβR KO P14 cells after poly(I:C) pre-treatment was seen in five separate 383 day 7 experiments. It could be argued that, with the IFN-αβR KO P14 cell experiment, there 384
were not enough cell divisions to detect a difference in division rate. We therefore examined 385 cells at days 8 and 9 after infection. At day 8 the cells had doubled in number over day 7, but 386 again no differences were seen in poly (I:C)-treated (8.7 ± 1.7 x 10 4 ) vs. control-treated (8. When we began these experiments we could not put IFN-αβR KO P14 cells exposed to 398 different environments in direct competition with each other in the same host, as we did in Fig. 5 1-3, 5, 8, 11, 23, 26, 32, 38-40, 43, 50) . Due to the lack of consensus from in vitro 423 systems, we sought to investigate the transient immune suppression induced by acute infections 424 with the arenaviruses LCMV and PV using adoptive transfer models to track and specifically 425 activate TCR-transgenic bystander CD8 T cells in vivo (Figure 1 ). We demonstrated here that 426 the proliferation of bystander CD8 T cells activated by cognate antigen during the acute phase of 427 virus infection in vivo was inhibited (Figure 2A Figure 2D ). Thus, while there was a strong adjuvant effect of viral infections on 432
T cell proliferation at the beginning of infection, there was a strong suppression of T cell 433 proliferation as early as three days into the infection. Our studies focused on T cells with 434 specificities for ligands other than those encoded by the infecting virus, but we presume that 435 these findings would also be relevant to late-comer virus-specific T cells whose TCR do not 436 encounter viral antigen until later in infection. 437
Despite the reported susceptibility of bystander CD8 T cells to AICD as measured in 438 vitro (1, 11, 50), the reduced proliferation of bystander CD8 T cells in our models was not 439 exclusively mediated by or dependent on Fas-FasL-and/or TNF-induced AICD (Table I) . In 440 addition, we could not convincingly show enhanced apoptosis in vivo, though it should be noted 441 that apoptotic cells can sometimes be cleared in vivo before they are readily detectable. 
